Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1268052-94-3

Ethyl 3,4-difluoro-2-iodophenylcarbaMate is a chemical compound characterized by the presence of ethyl, 3,4-difluoro, and 2-iodophenylcarbaMate groups. It is recognized for its unique chemical structure, which positions it as a potential drug candidate in pharmaceutical research and development. ethyl 3,4-difluoro-2-iodophenylcarbaMate's structural features suggest that it may possess specific biological activities, making it a promising candidate for the treatment of various medical conditions.

1268052-94-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1268052-94-3 Structure

  • Basic information

    1. Product Name: ethyl 3,4-difluoro-2-iodophenylcarbaMate
    2. Synonyms: ethyl 3,4-difluoro-2-iodophenylcarbaMate
    3. CAS NO:1268052-94-3
    4. Molecular Formula: C9H8F2INO2
    5. Molecular Weight: 327
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1268052-94-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 262.9±40.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.859±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 11.27±0.70(Predicted)
    10. CAS DataBase Reference: ethyl 3,4-difluoro-2-iodophenylcarbaMate(CAS DataBase Reference)
    11. NIST Chemistry Reference: ethyl 3,4-difluoro-2-iodophenylcarbaMate(1268052-94-3)
    12. EPA Substance Registry System: ethyl 3,4-difluoro-2-iodophenylcarbaMate(1268052-94-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1268052-94-3(Hazardous Substances Data)

1268052-94-3 Usage

Uses

Used in Pharmaceutical Research and Development:
Ethyl 3,4-difluoro-2-iodophenylcarbaMate is utilized as a potential drug candidate due to its unique chemical structure and the possibility of specific biological activities. It is employed for further study and development as a potential therapeutic agent for various medical conditions, with the aim of identifying its potential applications in treating certain diseases.
Further research is necessary to fully understand the compound's potential applications in the field of medicine and drug development, including its efficacy, safety, and mechanism of action. This will involve exploring its interactions with biological targets, assessing its pharmacokinetics and pharmacodynamics, and evaluating its potential for use in treating specific medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 1268052-94-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,8,0,5 and 2 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1268052-94:
(9*1)+(8*2)+(7*6)+(6*8)+(5*0)+(4*5)+(3*2)+(2*9)+(1*4)=163
163 % 10 = 3
So 1268052-94-3 is a valid CAS Registry Number.

1268052-94-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl (3,4-difluoro-2-iodophenyl)carbamate

1.2 Other means of identification

Product number -
Other names (3,4-Dichlorphenylimino)benzaldehyd

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1268052-94-3 SDS

1268052-94-3Relevant articles and documents

DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES

-

Page/Page column 99-100, (2011/04/13)

The present invention extends to the compound of formula I: or a prodrug, pharmaceutically acceptable salt, or solvate of said compound. Furthermore, the present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1268052-94-3